Advertisement

Biocontainment Principles for Pediatric Patients

  • Amy S. Arrington
Chapter

Abstract

The need for medical communities to prepare for highly hazardous communicable disease outbreaks was perhaps best exemplified in the 2014–2016 Ebola virus outbreak. To date, most efforts of preparedness have focused on adult medical providers, though it is critical that pediatric institutions achieve the same level of preparedness for children who may present with these illnesses. Care of pediatric patients exposed and/or infected with these unique pathogens requires advanced planning and training in order to offer the highest level of care while at the same time being able to ensure the safety of both the hospital staff and the community. In this chapter, we will discuss the basic principles of biocontainment and care in a unique pediatric setting and offer guidelines on how to navigate the identification, isolation, family-centered care, and clinical care of children with highly hazardous communicable diseases.

Keywords

Biocontainment Pediatric special isolation Ebola virus disease MERS-CoV SARS-CoV Viral hemorrhagic fevers Special isolation teams Parental visitation Highly hazardous communicable diseases 

References

  1. 1.
    Bitnun A, Read S, Tellier R, Petric M, Richardson SE. Severe acute respiratory syndrome-associated coronavirus infection in Toronto children: a second look. Pediatrics. 2009;123(1):97–101.CrossRefPubMedGoogle Scholar
  2. 2.
    Li AM, Chan CH, Chan DF. Long-term sequelae of SARS in children. Paediatr Respir Rev. 2004;5(4):296–9.CrossRefPubMedGoogle Scholar
  3. 3.
    Stockman LJ, Massoudi MS, Helfand R, Erdman D, Siwek AM, Anderson LJ, Parashar UD. Severe acute respiratory syndrome in children. Pediatr Infect Dis J. 2007;26(1):68–74.CrossRefPubMedGoogle Scholar
  4. 4.
    World Health Organization. Emergency preparedness, response: update 49 – SARS case fatality ratio, incubation period. 2003. http://www.who.int/csr/sarsarchive/2003_05_07a/en/. Accessed 9 Jan 2018.
  5. 5.
    Gao H, Yao H, Yang S, Li L. From SARS to MERS: evidence and speculation. Front Med. 2016;10(4):377–82.CrossRefPubMedGoogle Scholar
  6. 6.
    Zaki AM, Van Boheemen S, Bestebroer TM, Osterhaus AD, Fouchier RA. Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia. N Engl J Med. 2012;367:1814–20.CrossRefPubMedGoogle Scholar
  7. 7.
    Cowling B, Park M, Fang V, Wu P, Leung G, Wu J. Preliminary epidemiological assessment of MERS-CoV outbreak in South Korea, May to June 2015. Euro Surveill. 2015;20:7–13.CrossRefPubMedGoogle Scholar
  8. 8.
    Cho SY, Kang JM, Ha YE, et al. MERS-CoV outbreak following a single patient exposure in an emergency room in South Korea: an epidemiological outbreak study. Lancet. 2016;388(10048):994–1001.CrossRefPubMedGoogle Scholar
  9. 9.
    Aleanizy FS, Mohmed N, Alqahtani FY, El Hadi Mohamed RA. Outbreak of Middle East respiratory syndrome coronavirus in Saudi Arabia: a retrospective study. BMC Infect Dis. 2017;17(1):23.CrossRefPubMedPubMedCentralGoogle Scholar
  10. 10.
    Al-Tawfiq JA, Kattan RF, Memish ZA. Middle East respiratory syndrome coronavirus disease is rare in children: an update from Saudi Arabia. World J Clin Pediatr. 2016;5(4):391–6.CrossRefPubMedPubMedCentralGoogle Scholar
  11. 11.
    Thabet F, Chehab M, Bafaqih H, Al Mohaimeed S. Middle East respiratory syndrome coronavirus in children. Saudi Med J. 2015;36:484–6.CrossRefPubMedPubMedCentralGoogle Scholar
  12. 12.
    Memish ZA, Al-Taw q JA, Assiri A, AlRabiah FA, Al Hajjar S, Albarrak A, et al. Middle East respiratory syndrome coronavirus disease in children. Pediatr Infect Dis J. 2014;33:904–6.CrossRefPubMedGoogle Scholar
  13. 13.
    Shapiro M, London B, Nigri D, Shoss A, Zilber E, Fogel I. Middle East respiratory syndrome coronavirus: review of the current situation in the world. Disaster Mil Med. 2016;2:9.CrossRefPubMedPubMedCentralGoogle Scholar
  14. 14.
    The WHO MERS-CoV Research Group -. State of knowledge and data gaps of Middle East respiratory syndrome coronavirus (MERS-CoV) in humans. PLOS Currents Outbreaks. 2013 Nov 12. Edition 1. https://10.1371/currents.outbreaks.0bf719e352e7478f8ad85fa30127ddb8Google Scholar
  15. 15.
    Kourtis AP, Appelgren K, Chevalier MS, McElroy A. Ebola virus disease: focus on children. Pediatr Infect Dis J. 2015;34(8):893–7.CrossRefPubMedPubMedCentralGoogle Scholar
  16. 16.
    Helleringer S, Noymer A, Clark SJ, et al. Did Ebola relatively spare children? Lancet (London, England). 2015;386(10002):1442–3.CrossRefGoogle Scholar
  17. 17.
    Eriksson CO, Uyeki TM, Christian MD, et al. Care of the child with Ebola virus disease. Pediatr Crit Care Med. 2015;16(2):97–103.CrossRefPubMedGoogle Scholar
  18. 18.
    Saiman L, Arrington AS, Bell M. Preparing for emerging infectious diseases. JAMA Pediatr. 2017;171(5):411–2.CrossRefPubMedGoogle Scholar
  19. 19.
    Centers for Disease Control and Prevention. Travel health notices. https://wwwnc.cdc.gov/travel/notices.
  20. 20.
    Smith MW, Smith PW, Kratochvil CJ, Schwedhelm S. The psychosocial challenges of caring for patients with Ebola virus disease. Health Secur. 2017;15(1):104–9.CrossRefPubMedGoogle Scholar
  21. 21.
    Davies HD, Byington CL, Committee on Infectious Diseases. Parental presence during treatment of ebola or other highly consequential infection. Pediatrics. 2016;138(3):pii: e20161891.CrossRefGoogle Scholar
  22. 22.
    Johnson DW, Sullivan JN, Piquette CA, et al. Lessons learned: critical care management of patients with Ebola in the United States. Crit Care Med. 2015;43(6):1157–64.CrossRefPubMedGoogle Scholar
  23. 23.
    Halpern SD, Emanuel EJ. Ethical guidance on the use of life-sustaining therapies for patients with Ebola in developed countries. Ann Intern Med. 2015;162(4):304–5.CrossRefPubMedGoogle Scholar
  24. 24.
    Leligdowicz A, Fischer WA 2nd, Uyeki TM, et al. Ebola virus disease and critical illness. Crit Care. 2016;20(1):217.CrossRefPubMedPubMedCentralGoogle Scholar
  25. 25.
    Garibaldi BT, Chertow DS. High-containment pathogen preparation in the intensive care unit. Infect Dis Clin N Am. 2017;31(3):561–76.CrossRefGoogle Scholar
  26. 26.
    Kortepeter MG, Kwon EH, Hewlett AL, Smith PW, Cieslak TJ. Containment care units for managing patients with highly hazardous infectious diseases: a concept whose time has come. J Infect Dis. 2016;214(suppl 3):S137–41. Epub 2016 Sep 19.CrossRefPubMedGoogle Scholar
  27. 27.
    Garibaldi BT, Kelen GD, Brower RG, et al. The creation of a biocontainment unit at a tertiary care hospital. The Johns Hopkins medicine experience. Ann Am Thorac Soc. 2016;13(5):600–8.CrossRefPubMedGoogle Scholar
  28. 28.
    Smith PW, Anderson AO, Christopher GW, et al. Designing a biocontainment unit to care for patients with serious communicable diseases: a consensus statement. Biosecur Bioterror. 2006;4(4):351–65.CrossRefPubMedGoogle Scholar

Copyright information

© Springer International Publishing AG, part of Springer Nature 2018

Authors and Affiliations

  1. 1.Pediatric Special Isolation Unit, Pediatric Critical Care Medicine, Texas Children’s Hospital, Baylor College of MedicineHoustonUSA

Personalised recommendations